These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
503 related articles for article (PubMed ID: 15867214)
41. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis. Oh BK; Kim YJ; Park YN; Choi J; Kim KS; Park C Am J Gastroenterol; 2006 Apr; 101(4):831-8. PubMed ID: 16494581 [TBL] [Abstract][Full Text] [Related]
42. Detecting AFP mRNA in peripheral blood of the patients with hepatocellular carcinoma, liver cirrhosis and hepatitis. Yao F; Guo JM; Xu CF; Lou YL; Xiao BX; Zhou WH; Chen J; Hu YR; Liu Z; Hong GF Clin Chim Acta; 2005 Nov; 361(1-2):119-27. PubMed ID: 15993394 [TBL] [Abstract][Full Text] [Related]
43. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485 [TBL] [Abstract][Full Text] [Related]
44. [Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma]. Jia HL; Xing XJ; Ye QH; Qin LX Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):440-3. PubMed ID: 18795617 [TBL] [Abstract][Full Text] [Related]
45. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells]. Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080 [TBL] [Abstract][Full Text] [Related]
46. Real time quantification in plasma of human telomerase reverse transcriptase (hTERT) mRNA in patients with colorectal cancer. Lledó SM; Garcia-Granero E; Dasí F; Ripoli R; García SA; Cervantes A; Aliño SF Colorectal Dis; 2004 Jul; 6(4):236-42. PubMed ID: 15206965 [TBL] [Abstract][Full Text] [Related]
47. Determination of serum des-gamma-carboxy prothrombin levels in patients with small-sized hepatocellular carcinoma: comparison of the conventional enzyme immunoassay and two modified methods. Nomura F; Ishijima M; Horikoshi A; Nakai T; Ohnishi K Am J Gastroenterol; 1996 Jul; 91(7):1380-3. PubMed ID: 8677999 [TBL] [Abstract][Full Text] [Related]
48. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. Hsu HC; Cheng W; Lai PL Cancer Res; 1997 Nov; 57(22):5179-84. PubMed ID: 9371521 [TBL] [Abstract][Full Text] [Related]
49. [Perioperative detection of MAGE-1mRNA and AFP mRNA in peripheral blood of patients with hepatocellular carcinoma: relationships with recurrence]. Yang SZ; Dong JH; Zhu J; Li K; Zhang Y Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(9):595-8. PubMed ID: 15949354 [TBL] [Abstract][Full Text] [Related]
50. Sensitive and specific detection of circulating cancer cells in patients with hepatocellular carcinoma; detection of human telomerase reverse transcriptase messenger RNA after immunomagnetic separation. Waguri N; Suda T; Nomoto M; Kawai H; Mita Y; Kuroiwa T; Igarashi M; Kobayashi M; Fukuhara Y; Aoyagi Y Clin Cancer Res; 2003 Aug; 9(8):3004-11. PubMed ID: 12912949 [TBL] [Abstract][Full Text] [Related]
52. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand. Tangkijvanich P; Tosukhowong P; Bunyongyod P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):110-4. PubMed ID: 10695798 [TBL] [Abstract][Full Text] [Related]
53. Quantitative analysis of hTERT mRNA expression in colorectal cancer. Niiyama H; Mizumoto K; Sato N; Nagai E; Mibu R; Fukui T; Kinoshita M; Tanaka M Am J Gastroenterol; 2001 Jun; 96(6):1895-900. PubMed ID: 11419845 [TBL] [Abstract][Full Text] [Related]
54. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma. Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443 [TBL] [Abstract][Full Text] [Related]
55. Clinical application of determining serum AFP-IgM complexes for diagnosis of small hepatocellular carcinoma. Jiang J; Wu C; Shen Y; Xu B; Zheng X; Li X; Xu N Anticancer Res; 2011 Feb; 31(2):687-91. PubMed ID: 21378357 [TBL] [Abstract][Full Text] [Related]
56. Expression of cancer-testis antigen (CTA) in tumor tissues and peripheral blood of Chinese patients with hepatocellular carcinoma. Wu LQ; Lu Y; Wang XF; Lv ZH; Zhang B; Yang JY Life Sci; 2006 Jul; 79(8):744-8. PubMed ID: 16546222 [TBL] [Abstract][Full Text] [Related]
57. [Correlation between serum alpha-fetoprotein variant levels in patients with hepatocellular carcinoma and the presence of alpha-fetoprotein mRNA in the circulating blood]. Kang XY; Yin ZF; Qian HH; Wu ZD; Yu ZX; Wu MC Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):17-9. PubMed ID: 12546734 [TBL] [Abstract][Full Text] [Related]
58. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection? Jeng KS; Sheen IS; Tsai YC Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868 [TBL] [Abstract][Full Text] [Related]
59. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Marrero JA; Su GL; Wei W; Emick D; Conjeevaram HS; Fontana RJ; Lok AS Hepatology; 2003 May; 37(5):1114-21. PubMed ID: 12717392 [TBL] [Abstract][Full Text] [Related]
60. A novel biomarker TERTmRNA is applicable for early detection of hepatoma. Miura N; Osaki Y; Nagashima M; Kohno M; Yorozu K; Shomori K; Kanbe T; Oyama K; Kishimoto Y; Maruyama S; Noma E; Horie Y; Kudo M; Sakaguchi S; Hirooka Y; Ito H; Kawasaki H; Hasegawa J; Shiota G BMC Gastroenterol; 2010 May; 10():46. PubMed ID: 20482774 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]